International Clinical Trial: Phase II clinical study of irinotecan liposome combined with 5-FU/LV, targeted therpy and enlonstobart as first-line treatment for metastatic colorectal cancer

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132938) titled 'Phase II clinical study of irinotecan liposome combined with 5-FU/LV, targeted therpy and enlonstobart as first-line treatment for metastatic colorectal cancer' on Sept. 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shanxi Provincel Cancer Hospital

Condition: metastatic colorectal cancer

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-09-20

Target Sample Size: experimental group:46;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=337598

Published by HT Digital Content Services with permiss...